These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 571542)

  • 21. Dorsal raphe neurons: self-inhibition by an amphetamine-induced release of endogenous serotonin.
    Rebec GV; Curtis SD; Zimmerman KS
    Brain Res; 1982 Nov; 251(2):374-9. PubMed ID: 7139334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of destruction of midbrain raphe nuclei on the behavioral effects of dopaminergic substances and I-tryptophan].
    Allikmets LKh; Zharkovskiĭ AM; Arro AG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1977; 27(5):1030-5. PubMed ID: 563144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When injected into the fimbria-fornix/cingular bundle, not in the raphe, 5,7-dihydroxytryptamine prevents amphetamine-induced hyperlocomotion.
    Lehmann O; Jeltsch H; Bertrand F; Lazarus C; Will B; Cassel J
    Behav Brain Res; 2000 Sep; 114(1-2):213-7. PubMed ID: 10996062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open field study of stereotyped locomotor activity in amphetamine-treated rats.
    Schiørring E
    Psychopharmacology (Berl); 1979; 66(3):281-7. PubMed ID: 119275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
    Fessler RG; Sturgeon RD; Meltzer HY
    Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
    Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
    Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemical lesions of both dorsal and median raphe nuclei and changes in social and aggressive behaviour in rats.
    File SE; Deakin JF
    Pharmacol Biochem Behav; 1980 Jun; 12(6):855-9. PubMed ID: 7190702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of d-amphetamine-induced locomotor activity and stereotype behaviour by lesions of the superior colliculus.
    Pope SG; Dean P; Redgrave P
    Psychopharmacology (Berl); 1980; 70(3):297-302. PubMed ID: 6777805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of prenatal d-amphetamine administration on development and behavior of rats.
    Hitzemann BA; Hitzemann RJ; Brase DA; Loh HH
    Life Sci; 1976 Mar; 18(6):605-12. PubMed ID: 1263744
    [No Abstract]   [Full Text] [Related]  

  • 32. Cats develop tolerance to d-amphetamine's effects upon locomotion and stereotyped behaviors.
    Jacobs BL; Heym J; Trulson ME
    Eur J Pharmacol; 1981 Jan; 69(3):353-6. PubMed ID: 7194184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of lesion of the median raphe nucleus on motility and dopamine turnover.
    Funk KF; Westermann KH
    Pol J Pharmacol Pharm; 1979; 31(4):359-64. PubMed ID: 574958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depletion of brain serotonin following intra-raphe injections of 5,7-dihydroxytryptamine does not alter d-amphetamine self-administration across different schedule and access conditions.
    Fletcher PJ; Korth KM; Chambers JW
    Psychopharmacology (Berl); 1999 Sep; 146(2):185-93. PubMed ID: 10525754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of growth hormone on brain biogenic amine levels.
    Stern WC; Miller M; Jalowiec JE; Forbes WB; Morgane PJ
    Pharmacol Biochem Behav; 1975; 3(6):1115-8. PubMed ID: 1223899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of lesions of dorsal or median raphe nucleus on rat behavior.
    Przewłocka B; Kukułka L; Tatarczyńska E
    Pol J Pharmacol Pharm; 1977; 29(6):573-9. PubMed ID: 600858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lesions of the ventral medial tegmentum on locomotor activity, biogenic amines and responses to amphetamine in rats.
    Sessions GR; Meyerhoff JL; Kant GJ; Koob GF
    Pharmacol Biochem Behav; 1980 Apr; 12(4):603-8. PubMed ID: 7393956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiaton of neuropharmacological actions of apomorphine and d-amphetamine.
    Quock RM; Horita A
    Pharmacol Biochem Behav; 1976 Dec; 5(6):627-31. PubMed ID: 139615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat.
    Ogren SO; Archer T; Johansson C
    Neurosci Lett; 1983 Dec; 43(2-3):327-31. PubMed ID: 6687006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.